Glucose Health, Inc. Reports Sharply Higher Revenues & Gross Profits; Lower Operating Costs.
November 14 2018 - 6:20AM
InvestorsHub NewsWire
Glucose Health, Inc. Reports Sharply
Higher Revenues & Gross Profits; Lower Operating Costs.
BENTONVILLE, AR -- November 14,
2018 -- InvestorsHub NewsWire -- Glucose Health, Inc. (OTC:
“GLUC”) confirms the following selected financial data for the
9-month period ended September 30, 2018 vs. the 9-month period
ended September 30, 2017, posted this morning at
OTCMarkets.com.
- Revenues
of $158,482; a 117% increase compared to the prior 2017
period.
- Operating
Expenses of $54,590; a 16% decrease compared to the prior
2017 period.
- Gross
Profits of $86,162; a 51% increase compared to the prior
2017 period.
- Net Assets
of $165,256; a 138% increase compared to the prior 2017
period.
Company CEO, Murray Fleming, stated,
“our four delicious flavors of GlucoDown® Diabetic Formula Tea Mix
– Peach, Lemon, Super Berry and new Raspberry – are each formulated
with the most clinically efficacious and highest quality
ingredients ever offered to consumers in a diabetic nutritional
beverage product.”
- Clinically-efficacious: GlucoDown®
includes a unique form of 100% soluble fiber which, 15+ years of
clinical data1 indicates, is associated with beneficial
impacts on blood glucose, triglycerides, cholesterol levels as well
as digestive health.
- Highest
quality ingredients: Only the most bioavailable forms of
the key trace elements Chromium (Picolinate), Manganese (Citrate)
and Zinc (Picolinate) are utilized in GlucoDown® Diabetic Formula
Tea Mix supplements.2 Bioavailability refers to
the amount of a given nutrient that is actually absorbed and active
in the body.
1,2 For
citations visit the GlucoDown®
website.
Contact:
Murray Fleming
Glucose Health, Inc.
1-888-987-6315
xxx
Glucose Health (PK) (USOTC:GLUC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Glucose Health (PK) (USOTC:GLUC)
Historical Stock Chart
From Apr 2023 to Apr 2024